全文获取类型
收费全文 | 179967篇 |
免费 | 11208篇 |
国内免费 | 3490篇 |
专业分类
耳鼻咽喉 | 212篇 |
儿科学 | 5465篇 |
妇产科学 | 1479篇 |
基础医学 | 9385篇 |
口腔科学 | 492篇 |
临床医学 | 23615篇 |
内科学 | 100684篇 |
皮肤病学 | 423篇 |
神经病学 | 4209篇 |
特种医学 | 6309篇 |
外国民族医学 | 2篇 |
外科学 | 15542篇 |
综合类 | 12460篇 |
现状与发展 | 19篇 |
一般理论 | 11篇 |
预防医学 | 3843篇 |
眼科学 | 337篇 |
药学 | 7621篇 |
78篇 | |
中国医学 | 919篇 |
肿瘤学 | 1560篇 |
出版年
2023年 | 4366篇 |
2022年 | 7444篇 |
2021年 | 9417篇 |
2020年 | 8147篇 |
2019年 | 5419篇 |
2018年 | 6026篇 |
2017年 | 4902篇 |
2016年 | 5318篇 |
2015年 | 6069篇 |
2014年 | 13261篇 |
2013年 | 11425篇 |
2012年 | 11359篇 |
2011年 | 10508篇 |
2010年 | 9369篇 |
2009年 | 9141篇 |
2008年 | 7542篇 |
2007年 | 8158篇 |
2006年 | 7170篇 |
2005年 | 5956篇 |
2004年 | 5308篇 |
2003年 | 4794篇 |
2002年 | 4109篇 |
2001年 | 3797篇 |
2000年 | 3266篇 |
1999年 | 2768篇 |
1998年 | 1675篇 |
1997年 | 1382篇 |
1996年 | 1343篇 |
1995年 | 1192篇 |
1994年 | 993篇 |
1993年 | 844篇 |
1992年 | 1468篇 |
1991年 | 1281篇 |
1990年 | 1227篇 |
1989年 | 1107篇 |
1988年 | 989篇 |
1987年 | 658篇 |
1986年 | 418篇 |
1985年 | 467篇 |
1984年 | 737篇 |
1983年 | 681篇 |
1982年 | 477篇 |
1981年 | 385篇 |
1980年 | 342篇 |
1979年 | 272篇 |
1978年 | 250篇 |
1977年 | 183篇 |
1975年 | 200篇 |
1974年 | 198篇 |
1973年 | 156篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
《European journal of medical genetics》2022,65(6):104495
Spondyloepimetaphyseal dysplasias (SEMDs) belong to a clinically and genetically heterogeneous group of inherited skeletal disorders defined by a defect in the growth and shape of vertebrae, epiphyses and metaphyses. Rhizomelic SEMD is characterized by a disproportionate small stature caused by severe shortening and deformation of the limbs’ proximal bones, with the cranio-facial sphere unaffected. We report a second individual, an 8-year-old girl, with autosomal recessive rhizomelic SEMD associated with a homozygous exonic missense variant, c.226G > A p.(Glu76Lys), in GNPNAT1 identified by trio genome sequencing. Our data corroborate the recent findings of Ain et al. and further delineate the clinical and radiographic features of this form of SEMD associated with rhizomelic dysplasia while outlining a potential hotspot in this newly described genetic disorder. 相似文献
62.
《The Canadian journal of cardiology》2022,38(7):1100-1110
The Fontan procedure is a staged palliation for various complex congenital cardiac lesions, including tricuspid atresia, pulmonary atresia, hypoplastic left heart syndrome, and double-inlet left ventricle, all of which involve a functional single-ventricle physiology. The complexity of the patients’ original anatomy combined with the anatomic and physiologic consequences of the Fontan circulation creates challenges. Teens and adults living with Fontan palliation will need perioperative support for noncardiac surgery, peripartum management for labour and delivery, interventions related to their structural heart disease, electrophysiology procedures, pacemakers, cardioversions, cardiac surgery, transplantation, and advanced mechanical support. This review focuses on the anesthetic and intensive care unit (ICU) management of these patients during their perioperative journey, with an emphasis on the continuity of preintervention planning, referral pathways, and postintervention ICU management. Requests for recipes and doses of medications are frequent; however, as in normal anesthesia and ICU practice, the method of anesthesia and dosing are dependent on the presenting medical/surgical conditions and the underlying anatomy and physiologic reserve. A patient with Fontan palliation in their early 20s attending school full-time with a cavopulmonary connection is likely to have more reserve than a patient in their late 40s with an atriopulmonary Fontan at home waiting for a heart transplant. Each case will require an anesthetic and critical care plan tailored to the situation. The critical care environment is a natural extension of the anesthetic management of a patient, with complex considerations for a patient with Fontan palliation. 相似文献
63.
64.
《Current problems in cardiology》2022,47(10):101297
Atrial fibrillation (AF) has a strong impact on the quality of life (QOL) of patients and anticoagulation has a lot to do with it. We evaluated the QOL of patients with nonvalvular AF who start treatment with apixaban in Latin America. QOL was analyzed through a questionnaire developed to evaluate anticoagulated patients, which was completed by them 3 months after starting treatment. We included 521 patients from Uruguay, Bolivia, Ecuador, Paraguay, and Peru. A high index of general treatment satisfaction (5.34 ± 0.46) and self-efficacy (5.11 ± 0.68) were observed; the distress index was low (1.77 ± 0.88), as was the perception of daily hassles (1.35 ± 0.49) and strain social network related to medication (1.21 ± 0.34). Patients with AF who started treatment with apixaban has good satisfaction and self-efficacy scores with low index of stress, few daily limitations and social disruptions. 相似文献
65.
Triposkiadis Filippos Xanthopoulos Andrew Skoularigis John Starling Randall C. 《Heart failure reviews》2022,27(6):1991-2003
Heart Failure Reviews - The nitric oxide (NO)–guanylate cyclase (GC)–cyclic guanosine monophosphate (cGMP) pathway plays an important role in cardiovascular, pulmonary and renal... 相似文献
66.
《Current problems in cardiology》2022,47(9):100902
Genistein, an isoflavone in soybean products has potential cardio-protective effects and is used also as an alternative for estrogen therapy in postmenopausal women. However, results in this regard are inconsistent and also, not all risk factors related to cardiovascular supportive effects have been meta-analyzed. We searched PubMed, Scopus, ISI Web of Science, and Google Scholar from inception up to October 2020. Random-effects meta-analysis was used for data synthesis. The search included studies with information on genistein supplementation and lipid profile [triglycerides (TG), total cholesterol (TC),low-density lipoprotein (LDL-C), and high-density lipoprotein HDL-C)], systolic and diastolic blood pressure (SBP & DBP), body mass index [BMI] and body weight. Pooled results of studies showed that genistein intake significantly reduced TC [95%CI: -0.49(-0.80, -0.18); P=0.002)], LDL-C [95%CI: -0.60(-1.10, -0.10); P=0.018)] and SBP [95%CI: -0.52(-0.90, -0.14); P=0.007)]. DBP, HLD-C, TG, BMI, and body weight showed no meaningful improvement. Subgroup analysis showed that LDL-C and SBP were reduced more effectively in postmenopausal women with metabolic syndrome. Genistein intake more than 6 months showed a greater effect on lowering cholesterol -0.76(-1.27, -0.24), SBP [-0.39(-0.70, -0.08)] and DBP -0.40(-0.81, -0.00) and increasing TG and LDL-C. This meta-analysis provides consistent evidence that genistein intake reduces the CVD risk factors of TC, LDL-C, and SBP significantly. 相似文献
67.
Oxidative stress and inflammation are two possible mechanisms related to nephrotoxicity caused by environmental pollutants. Ellagic acid, a powerful antioxidant phytochemical, may have great relevance in mitigating pollutant-induced nephrotoxicity and preventing the progression of kidney disease. This review discusses the latest findings on the protective effects of ellagic acid, its metabolic derivatives, the urolithins, against kidney toxicity caused by heavy metals, pesticides, mycotoxins, and organic air pollutants. We describe the chelating, antioxidant, anti-inflammatory, antifibrotic, antiautophagic, and antiapoptotic properties of ellagic acid to attenuate nephrotoxicity. Furthermore, we present the molecular targets and signaling pathways that are regulated by these antioxidants, and suggest some others that should be explored. Nevertheless, the number of reports is still limited to establish the efficacy of ellagic acid against kidney damage induced by environmental pollutants. Therefore, additional preclinical studies on this topic are required, as well as the development of well-designed clinical trials. 相似文献
68.
69.
70.